Skip to content

Otilimab

Otilimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor.
Trade Name
Common Name Otilimab
Indication
Drug Class Monoclonal antibodies: immunomodulating
Otilimab
Get full access now